One recent study reported that microglial-specific expression levels of M2 markers (Arg1, Ym1) were significantly downregulated at the early chronic phase in a pilocarpine-induced epilepsy model (Benson et al., 2015). The gene discussed is ARG1; the disease is epilepsy.